| Bone metastases from differentiated thyroid carcinoma. | |
| | |
MedLine Citation:
|
PMID: 18310274 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The presence of distant metastases from differentiated thyroid carcinoma decreases the 10-year survival of patients by 50%. Bone metastases represent a frequent complication especially of follicular thyroid cancer and severely reduce the quality of life causing pain, fractures, and spinal cord compression. Diagnosis is established by correlating clinical suspicion with imaging. Imaging is essential to detect, localize, and assess the extension of the lesions and should be used in conjunction with clinical evidence. Bone metastases are typically associated with elevated markers of bone turnover, but these markers have not been evaluated in differentiated thyroid cancer. Skeletal and whole-body magnetic resonance imaging and fusion 2-deoxy-2-[18F]fluoro-D-glucose whole-body positron emission tomography/computed tomography (PET/CT) are the best anatomic and functional imaging techniques available in specialized centers. For well-differentiated lesions, iodine-PET scan combined (124)I-PET/CT is the newest imaging development and (131)I is the first line of treatment. Bisphosphonates reduce the complications rate and pain, alone or in combination with radioiodine, radionuclides, or external beam radiotherapy and should be employed. Surgery and novel minimally invasive consolidation techniques demand an appropriate patient selection for best results on a multimodal approach. Basic research on interactions between tumor cells and bone microenvironment are identifying potential novel targets for future more effective therapeutic interventions for less differentiated tumors. |
| | |
Authors:
|
M M Muresan; P Olivier; J Leclère; F Sirveaux; L Brunaud; M Klein; R Zarnegar; G Weryha |
Related Documents
:
|
19520214 - Impact of integrated pet/ct in the staging of oesophageal cancer: a uk population-based... 11079584 - Whole-body fdg positron emission tomographic imaging for staging esophageal cancer comp... 10707924 - Values and limitations of 18f-fluorodeoxyglucose-positron-emission tomography with preo... 12468334 - Pet-ct localizes previously undetectable metastatic lesions in recurrent fallopian tube... 15627604 - In vivo 3d mri of insect brain: cerebral development during metamorphosis of manduca se... 8536394 - Accuracy of ct in predicting the cause of bronchiectasis. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Endocrine-related cancer Volume: 15 ISSN: 1351-0088 ISO Abbreviation: Endocr. Relat. Cancer Publication Date: 2008 Mar |
Date Detail:
|
Created Date: 2008-03-03 Completed Date: 2008-05-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9436481 Medline TA: Endocr Relat Cancer Country: England |
Other Details:
|
Languages: eng Pagination: 37-49 Citation Subset: IM |
Affiliation:
|
Endocrinology Department and Nuclear Medicine Department, Hôpital Brabois Adultes, CHU Nancy, Vandoeuvre, France. m.muresan@chr-metz-thionville.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Bone Neoplasms / secondary*, therapy Cell Differentiation* Humans Thyroid Neoplasms / pathology*, therapy |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Aromatase inhibitors for breast cancer: different structures, same effects?
Next Document: Thyroid stem cells: lessons from normal development and thyroid cancer.